DiRECT and indirect paths to reducing cardiovascular risk in diabetes: insights from Diabetes UK 2019.

The 2019 Diabetes UK conference in Liverpool was notable for the range of home-grown innovative research – much of which had clinical translational relevance – on display. Examples ranged from updates on the potential utility of pharmacogenomics through advances in the diagnosis and care of patients with monogenic forms of diabetes to an intriguing demonstration of the potential value of current assays of C-peptide to reclassify diabetes subtypes. Other presentations at the conference also served to illustrate the gathering momentum of precision medicine in diabetes.